Skip to content
History timeline SK hynix 2019 History timeline SK biopharm 2019 History timeline 2020 14th skms
Previous page Next page


SK biopharmaceuticals Becomes First Korean Company to Receive U.S. FDA Approval for New Drug

SK biopharmaceuticals becomes the first Korean company to independently bring a compound from drug discovery to approval by the U.S. Food and Drug Administration (FDA). The compound, Cenobamate, will be sold as Xcopri for the treatment of partial-onset seizures in adults. SK biopharmaceuticals seeks to further expand its U.S. workforce to support the launch of Xcopri, the company's first commercial product.

More History